Jefferies Starts Ambow Education (AMBO) at Buy
Tweet Send to a FriendGet Alerts AMBO Hot Sheet
Price: $0.95 --0%
Rating Summary:
5 Buy, 1 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 12 | Down: 19 | New: 22
Rating Summary:
5 Buy, 1 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 12 | Down: 19 | New: 22
Trade AMBO Now!
Jefferies initiates coverage on Ambow Education (NYSE: AMBO) with a Buy. PT $10.00.
The firm comments, "We estimate higher than market average growth in the career enhancement segment attributed to Ambow’s leading position and continuous networking with IT companies and universities. The K-12 tutoring segment would be another driver due to Ambow’s presence in less penetrated second tier cities. All acquisition issues have been cleared up by YE11. Attractive valuation for the growth and fundamentals, we initiate with Buy."
For an analyst ratings summary and ratings history on Ambow Education click here. For more ratings news on Ambow Education click here.
Shares of Ambow Education closed at $7.24 yesterday, with a 52 week range of $1.63-$9.59.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
The firm comments, "We estimate higher than market average growth in the career enhancement segment attributed to Ambow’s leading position and continuous networking with IT companies and universities. The K-12 tutoring segment would be another driver due to Ambow’s presence in less penetrated second tier cities. All acquisition issues have been cleared up by YE11. Attractive valuation for the growth and fundamentals, we initiate with Buy."
For an analyst ratings summary and ratings history on Ambow Education click here. For more ratings news on Ambow Education click here.
Shares of Ambow Education closed at $7.24 yesterday, with a 52 week range of $1.63-$9.59.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- UPDATE: Keryx Biopharma (KERX) Patents Strong; JPMorgan Starts at Overweight
- Wells Fargo Starts CorEnergy Infrastructure Trust (CORR) at Outperform
- UPDATE: UBS Starts Insmed (INSM) at Buy
Create E-mail Alert Related Categories
New CoverageRelated Entities
Jefferies & Co
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
